Eribulin Mesylate

• Catalog Number: orb1089624
• Category: Small Molecules
• Description: Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma.
• CAS Number: [441045-17-6]
• MW: 826.00222
• SMILES: CS(=O)(O)=O.NC[C@@H](O)C[C@H]1[C@@H](OC)[C@H]2[C@H](C[C@@H]3C(=C)[C@@H](C)C[C@@H](CC[C@H]4C(=C)C[C@@H](O4)CCC56O[C@H]7[C@@H]8[C@@H](O[C@H]7C6)[C@@H](O5)[C@@H]9[C@H](CC[C@H](CC(=O)C2)O9)O8)O3)O1
• Formula: C₄₀H₅₉NO₁₁.CH₄O₃S
• Note: For research use only
• Expiration Date: 12 months from date of receipt.